Impact of COVID-19 pandemic on central-line-associated bloodstream infections during the early months of 2020, National Healthcare Safety Network
- PMID: 33719981
- PMCID: PMC8047389
- DOI: 10.1017/ice.2021.108
Impact of COVID-19 pandemic on central-line-associated bloodstream infections during the early months of 2020, National Healthcare Safety Network
Abstract
Data reported to the Centers for Disease Control and Prevention's National Healthcare Safety Network (CDC NHSN) were analyzed to understand the potential impact of the COVID-19 pandemic on central-line-associated bloodstream infections (CLABSIs) in acute-care hospitals. Descriptive analysis of the standardized infection ratio (SIR) was conducted by location, location type, geographic area, and bed size.
References
-
- FY 2021 IPPS final rule home page. Centers for Medicare and Medicaid Services website. https://www.cms.gov/medicare/acute-inpatient-pps/fy-2021-ipps-final-rule.... Updated January 2021. Accessed February 18, 2021.
-
- 2019 National and state healthcare-associated infections progress report. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/data/portal/progress-report.html. Published 2020. Accessed February 2, 2021.
-
- National Health Safety Network. Bloodstream infection event (central-line–associated bloodstream infection and non–central-line–associated bloodstream infection) NHSN protocol. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Updated January 2021. Accessed February 3, 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical